Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-15-000075

CEO bought 3,500 shares at $0.20 ($700)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-12-23 Purchase : show line 1 in the form +1,500 $0.20 $300 6,906,814 D
2015-12-24 Purchase : show line 2 in the form +2,000 $0.20 $400 6,908,814 D
Open-market purchases · 3,500 sh · avg $0.20 · $700
Loading xslF345X03/primary_doc.xml…